This Class II recall was initiated due to a risk of clinicians encountering issues when deploying the Trilogy Transcatheter ...
A urologist explains how prostate treatments differ in relief, side effects, recovery, and how well they fit individual needs.
No hospitalized patient loves getting a urinary catheter. But if they must have one, the last thing they want is a urinary ...
Many U.S. hospitals aren’t taking simple steps to lower the odds that patients won’t get a urinary tract infection from their ...
BOSTON & LONDON, September 28, 2026--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announces the launch ...
MarketsandMarkets™ projects the global catheters market to grow from USD 30.53 billion in 2025 to USD 45.99 billion by 2030, ...
A national survey of 422 neonatologists and cardiologists reveals deep disagreement over which echocardiographic markers ...
Teleflex Incorporated (NYSE: TFX) reported that its antiseptic-coated central venous catheters were associated with a 70% ...
New ready-to-use hydrophilic catheter designed to make self-catheterization a smaller part of everyday life, launching initially across the US and Canada in September, with other markets to follow.
New ready-to-use hydrophilic catheter designed to make self-catheterization a smaller part of everyday life, launching initially across the US and Canada in September, with other markets to follow.
Houston Methodist researchers have been awarded a five-year, $3.28 million grant from the National Institutes of Health to ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that its NANOPULSE-AF Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results